(1)
Vancouver, British Columbia (Newsfile Corp. - March 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ( BioMark ) is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes after the organizers of the competition, the Canadian Cancer Society/Canadian Institutes of Health Research - Institute of Cancer Research, and Brain Canada Foundation, evaluated the full proposal for its relevance to funding opportunities in the prevention and early detection of cancer. The funding application is entitled A novel rapid, liquid biopsy early-stage lung cancer diagnostic test . The grant was for $150,000.
Artificial intelligence leads NATO’s new strategy for emerging and disruptive tech (Getty Images) STUTTGART, Germany NATO and its member nations have formally agreed upon how the alliance should target and coordinate investments in emerging and disruptive technology, or EDT, with plans to release artificial intelligence and data strategies by the summer of 2021. In recent years the alliance has publicly declared its need to focus on so-called EDTs, and identified seven science and technology areas that are of direct interest. Now, the NATO enterprise and representatives of its 30 member states have endorsed a strategy that shows how the alliance can both foster these technologies through stronger relationships with innovation hubs and specific funding mechanisms and protect EDT investments from outside influence and export issues.
It s good to talk telecoms: Why the forgotten sector for equity investors is key to the digital revolution
Comms giants crucial elements in economic recovery
With telecoms offering investors opportunities, the sun is not setting on the sector just yet
Jim Wright
The telecommunications sector has been a graveyard for investors for many years now, with shareholder returns falling way short of the wider market. Over the past five years, the MSCI World Index has delivered a return of 81%.
In comparison, the MSCI World Telecom Services index has returned 3%. Not per annum; in total. Perhaps the most remarkable aspect of this huge underperformance has been that it has occurred when the.
Valo Health Receives $110 Million In Funding From Koch Disruptive Technologies To Close Series B
Valo s CEO To Provide Insights On Programs And Opal Platform At Barclays Global Healthcare Conference
News provided by
Share this article
Share this article
BOSTON, March 9, 2021 /PRNewswire/ Valo Health LLC (Valo), a technology company transforming the drug discovery and development process and seeking to accelerate the creation of life-changing drugs, today announced the final closing of its Series B at $300 million, including a $110 million investment from Koch Disruptive Technologies (KDT). This brings the overall funding of Valo to over $450 million.
With this investment Valo will continue to scale its Opal Computational Platform